GlycoNAVI: CheGly (Chemical Glycosylation)
ACT

Cleistrioside-6

ID Compound Name Target Name Species Assay Method Activity Value Conditions DOI
act2226Cleistrioside-6E. coli MG1655MIC (μM)>6410.1021/ml300303g
act2234Cleistrioside-6E. coli impMIC (μM)3210.1021/ml300303g
act2242Cleistrioside-6B. subtilis JH642MIC (μM)810.1021/ml300303g
act2250Cleistrioside-6NCI-H460MIC (μM)12.510.1021/ml300303g
act2258Cleistrioside-6RPMI-8226 (leukemia)GI50 (μM)1.0010.1021/ml300303g
act2264Cleistrioside-6SR (leukemia)GI50 (μM)1.2010.1021/ml300303g
act2270Cleistrioside-6A549 (nonsmall cell lung cancer)GI50 (μM)2.0810.1021/ml300303g
act2276Cleistrioside-6NCI-H460 (nonsmall cell lung cancer)GI50 (μM)1.5410.1021/ml300303g
act2282Cleistrioside-6HCT-15 (colon cancer)GI50 (μM)7.3810.1021/ml300303g
act2288Cleistrioside-6HT-29 (colon cancer)GI50 (μM)1.2110.1021/ml300303g
act2294Cleistrioside-6SF-539 (CNS cancer)GI50 (μM)3.1010.1021/ml300303g
act2300Cleistrioside-6SNB-75 (CNS cancer)GI50 (μM)0.9010.1021/ml300303g
act2306Cleistrioside-6MDA-MB-435 (melanoma)GI50 (μM)1.4910.1021/ml300303g
act2312Cleistrioside-6SK-MEL-5 (melanoma)GI50 (μM)1.2310.1021/ml300303g
act2318Cleistrioside-6OVCAR-3 (ovarian cancer)GI50 (μM)1.4910.1021/ml300303g
act2324Cleistrioside-6ADR-R (ovarian cancer)GI50 (μM)7.9210.1021/ml300303g
act2330Cleistrioside-6A498 (renal cancer)GI50 (μM)5.1310.1021/ml300303g
act2336Cleistrioside-6CAKI-1 (renal cancer)GI50 (μM)6.5710.1021/ml300303g
act2342Cleistrioside-6PC-3 (prostate cancer)GI50 (μM)0.8910.1021/ml300303g
act2348Cleistrioside-6DU-145 (prostate cancer)GI50 (μM)2.4810.1021/ml300303g
act2354Cleistrioside-6MCF7 (breast cancer)GI50 (μM)1.6210.1021/ml300303g
act2360Cleistrioside-6BT-549 (breast cancer)GI50 (μM)4.5410.1021/ml300303g